Captopril (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Captopril drug offered from Mylan Institutional Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | captopril |
| SUBSTANCE NAME: | CAPTOPRIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1996-02-14 |
| END MARKETING DATE: | 0000-00-00 |
Captopril HUMAN PRESCRIPTION DRUG Details:
| Item Description | Captopril from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5(mg/1) |
| START MARKETING DATE: | 1996-02-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51079-863_40e525f9-869d-1e39-e054-00144ff88e88 |
| PRODUCT NDC: | 51079-863 |
| APPLICATION NUMBER: | ANDA074434 |
Other CAPTOPRIL Pharmaceutical Manufacturers / Labelers:
